Quick Dispatch:
Your ascendis transcon glp-1 program Novo puts $285m into monthly GLP-1 based on Ascendis tech orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your ascendis transcon glp-1 program Novo puts $285m into monthly GLP-1 based on Ascendis tech ships.
Need Help?
Questions about ascendis transcon glp-1 program Novo puts $285m into monthly GLP-1 based on Ascendis tech, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for ascendis transcon glp-1 program Novo puts $285m into monthly GLP-1 based on Ascendis tech in your area.
Ozempic maker Novo Nordisk is working on a once-monthly weight-loss drug
21.15
Novo Nordisk Taps Ascendis For Development Of A Once-Monthly GLP-1 Agonist
27.26
Novo pens $285M biobucks deal to use Ascendis' tech to create monthly GLP-1 agonist
22.71
Novo inks Ascendis deal to develop long-acting GLP-1, other metabolic drugs
20.14
Novo Nordisk taps Ascendis in $285 million GLP-1 deal
22.07
Novo Nordisk, Ascendis Ink $285M GLP-1 Pact
22.37
The Role of PEG in TransCon-Based Long-Acting Drug Development
24.83
